People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aerie Pharmaceuticals Inc | — | Biotechnology | Series D+ | $189.6M | $5.2B | 2014 |
| Iantrek, Inc. | — | Biotechnology | Series B | $58.2M | $152.2M | 2020 |
| Neurotrigger Ltd. | — | Biotechnology | Seed | $2.9M | $1.7M | 2024 |
| KYS Vision, Inc. | — | Other Technology | Seed | $2.2M | $5.7M | 2025 |
James Mazzo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Mazzo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tsontcho Ianchulev | 2 | 5 |
| Michael Haydin | 2 | 2 |
| Stephen Bloch | 1 | 15 |
| Brian Levy | 1 | 8 |
| ANAND MEHRA | 1 | 7 |
| Marc-Andre Marcotte | 1 | 6 |
| DENNIS HENNER | 1 | 5 |
| David Epstein | 1 | 5 |
| Gerald Cagle | 1 | 4 |
| Peter Pham | 1 | 3 |
| DAVID GRYSKA | 1 | 3 |
| Casey K. Tansey | 1 | 3 |
| Richard Rubino | 1 | 3 |
| DENNIS J HENNER | 1 | 2 |
| Jeffry K. Weinhuff | 1 | 2 |
| DAVID MACK | 1 | 2 |
| Andrew Corley | 1 | 2 |
| GEOFFREY DUYK | 1 | 2 |
| GEOFFREY J DUYK | 1 | 2 |
| Ali Tafreshi | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.